29.01.2010 • NewsHenkelprofits

Henkel Sees Drop in Sales and Earnings in 2009; Performance Still Better Than Expected

Henkel has announced that 2009 sales will decline by 3.5% to around €13.57 billion. The company said it expects adjusted earnings to fall to €1.91 per preferred share from €2.19 a share a year ago. However, the company concluded that the 2009 recession year has been "better than anticipated." The company has posted a strong business performance for Q4 2009, citing better-than-expected developments in their Laundry & Home Care and Adhesive Technologies business sectors. Adjusted return on sales (EBIT) further increased in the fourth quarter to 12.4%. The company is scheduled to release final figures on Feb. 25

Company

Henkel AG & Co. KGaA

Henkelstr. 67
40589 Düsseldorf
Germany

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.